Micron Technology, Inc. is still a strong buy after 300% growth, with surging revenue and AI-driven potential. Learn more ...

For the November quarter, the chip company reported earnings per share of $4.78, compared to Wall Street’s consensus estimate ...

Stifel is far from the only firm boosting targets and touting a bullish tone. Goldman Sachs' analysts expect Micron to ...

Micron Technology, Inc. posts soaring revenue and margins amid DRAM shortage. Click for this updated look at MU earnings following the latest earnings report.

When parallels are drawn between a company and Nvidia, investors pay attention. That’s exactly how Morgan Stanley framed ...

Micron is well-positioned to accelerate its game-changing growth trajectory in 2026, driving significant improvements in cash ...

With DDR5 more than tripling in price in recent weeks, the whole industry is in a panic about how this will affect PC gamers, ...

Stocks jumped following the latest reading on consumer inflation that could help set expectations for the path of interest ...

Detailed price information for Lumentum Holdings (LITE-Q) from The Globe and Mail including charting and trades.

Antibody treatments for cancer and other diseases are typically delivered intravenously, because of the large volumes that are needed per dose. This means the patient has to go to a hospital for every ...

Major stock indexes ended mixed Thursday, with the Dow Jones Industrial Average and S&P 500 closing at record highs but the ...